Low "t" as in "template": How to sell disease

JAMA Internal Medicine

Volumn 173, Issue 15, 2013, Pages 1460-1462

  Schwartz, Lisa M ^a,b,c   Woloshin, Steven ^a,b,c  

^a VA MEDICAL CENTER   (United States)

^b DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^c Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE;

AGING; DRUG INDUSTRY; DRUG MARKETING; HEALTH PROMOTION; LIBIDO; MEN'S HEALTH; NOTE; PHYSICIAN; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SEXUAL SATISFACTION;

EID: 84883227516     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.7579     Document Type: Note

References (10)

1. Low-T and Low-O. The Colbert Report. Comedy Central television. December 4, 2012. http://www.colbertnation.com/the-colbert-reportvideos/ 421822/december-04-2012/low-t-low-o. Accessed April 21, 2013.
2. Abbott Laboratories. Is It [LowT]? http://www.isitlowt.com. Accessed April 12, 2013.
3. Dobrow L. All-star large pharma marketing team of the year: AndroGel. Medical Marketing & Media. January 2, 2013. http://www.mmm-online.com/all- star-large-pharma-marketing-team-of-the-year-androgel/article/273242/. Accessed April 29, 2013.
4. Braun SR. Promoting "Low T": a medical writer's perspective [published online June 3, 2013]. JAMA Intern Med. doi:10.1001/jamainternmed. 2013.6892.
5. Bhasin S, Cunningham GR, Hayes FJ, et al; Task Force, Endocrine Society. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(6):2536-2559.
6. Dohle GR, Arver S, Bettocchi C, Kliesch S, Punab M, de RondeW. Guideline on Male Hypogonadism. Anhem, The Netherlands: European Association of Urology; 2012.
7. Lewis BH, LegatoM, Fisch H. Medical implications of the male biological clock. JAMA. 2006;296(19):2369-2371.
8. Bunyavanich S. Low testosterone could kill you. ABC News. June 6, 2007. http://abcnews.go.com/Health/ActiveAging/story?id=3247773# .UXGsoErTDFc. Accessed April 21, 2013.
9. Basaria S, Coviello AD, Travison TG, et al. Adverse events associated with testosterone administration. N Engl J Med. 2010;363(2):109-122.
10. AndroGel 1.62%[package insert]. North Chicago, IL: Abbott Laboratories; 2012. http://www.accessdata.fda.gov/drugsatfda-docs/label/2012/022309s001lbl. pdf.